European Urology Oncology
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
European Urology Oncology
Jul 11, 2024, 12:34 |
Insight
Ravi Madan: Enzalutamide Monotherapy in the EMBARK Trial Should Be Practice-changing
Ravi Madan, Clinical researcher focused on Prostate Cancer at National Cancer Institute, shared a post…
Jul 10, 2024, 07:36 |
Blog
Sumanta K. Pal: Examining docetaxel, apalutamide and radiotherapy in PSA recurrent prostate cancer
Sumanta K. Pal shared on X: "Congrats Tian Zhang and team on this terrific paper in…
Jul 8, 2024, 15:44 |
Insight
Julien Sarkis: Happy to see our NEPRAH study published in European Urology Oncology
Julien Sarkis, Urology Resident at Henri-Mondor, shared on X: "Happy to see our NEPRAH study…
Jun 25, 2024, 03:54 |
Insight
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System
Maria Natalia Gandur Quiroga shared on LinkedIn: "Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring…
Jun 23, 2024, 04:34 |
Insight
Ashish Kamat: IBCG scoring system and substratification model for IR NMIBC
Ashish Kamat, Endowed Professor of Urologic Oncology (Surgery) and Cancer Research at University of Texas MD…
Jun 20, 2024, 06:25 |
Blog
Petros Grivas: Congratulations Neeraj Agarwal Neal Shore and all authors!
Petros Grivas shared a post by Neeraj Agarwal, on X: "Congratulations Neeraj Agarwal Neal Shore and all…
Jun 17, 2024, 13:17 |
Insight
Neeraj Agarwal: Expert guidance on management of AEs in patients with prostate cancer
Neeraj Agarwal shared on X/Twitter: "Just in European Urology Oncology. Expert guidance (by modified Delphi panel…
May 29, 2024, 13:04 |
Insight
Chris Wong: My recent publications on urothelial carcinoma
Chris Wong, Urology Resident at NTEC Surgery, shared on LinkedIn: "My recent publications on urothelial…
Apr 7, 2024, 23:57 |
Insight
Integrating androgen deprivation therapy with metastasis-directed therapy leads to improved progression-free survival - IOSI Oncology Institute of Southern Switzerland - EOC
Dec 15, 2023, 06:25 |
Drugs
Andrew Armstrong: Pleased to share our ARCHES analysis of efficacy, safety, and QOL of enza/ADT in men w/mHSPC by age
Andrew Armstrong, Professor of Medicine, Surgery, Pharmacology and Cancer Biology at the Duke Cancer Institute,…
All:
10
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube